HS-20004

· Jiangsu Hansoh Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for HS-20004, covering 2016-04-21 to 2022-11-07. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study to Evaluate the Efficacy and Safety of HS-20004 in Type 2 Diabetes Subjects. [Phase 2]